GNNSF

GENSCRIPT BIOTECH CRP ORD by Genscript Biotech Corp (GNNSF)

About GENSCRIPT BIOTECH CRP ORD by Genscript Biotech Corp (GNNSF)

Genscript Biotech Corp. operates as a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Life-science Services and Products, Biologics Development Services, and Industrial Synthetic Biology Products. The Life-science Services and Products segment provides research services and products used for life-science research and application. The Biologics Development Services segment focuses on services aimed to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and CGT products with an integrated platform. The Industrial Synthetic Biology Products segment comprises of industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Hong Kong.

Details

Daily high
$2.90
Daily low
$2.83
Price at open
$2.83
52 Week High
$2.90
52 Week Low
$1.30
Market cap
4.3B
Dividend yield
0.00%
Volume
6,378
Avg. volume
70
P/E ratio
-8.11

GENSCRIPT BIOTECH CRP ORD by Genscript Biotech Corp News

Details

Daily high
$2.90
Daily low
$2.83
Price at open
$2.83
52 Week High
$2.90
52 Week Low
$1.30
Market cap
4.3B
Dividend yield
0.00%
Volume
6,378
Avg. volume
70
P/E ratio
-8.11